Stay updated on CANDOR Clinical Trial
Sign up to get notified when there's something new on the CANDOR Clinical Trial page.

Latest updates to the CANDOR Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedGlossary feature added; QC/FEAR Act related labels updated, and the page version updated from v3.3.4 to v3.4.0.SummaryDifference0.1%

- Check21 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4, a minor update with no changes to study content or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check49 days agoChange DetectedThe study locations were expanded with new site entries across the US (Florida, Georgia, Illinois, Indiana, Mississippi, New Jersey, New York, North Carolina, Ohio, South Carolina, Texas), Australia (New South Wales, Queensland, South Australia, Victoria), Canada (Alberta, Ontario, Quebec), Japan (Aichi-ken, Chiba, Fukuoka, Gifu, Gunma, Kyoto, Niigata, Okayama-ken, Osaka, Saitama, Tochigi, Tokushima, Tokyo), and Spain (Castilla León, Cataluña, Navarre); several previously listed locations were removed in this revision (v3.3.3).SummaryDifference2%

- Check71 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2; no user-facing content or study details were changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check77 days agoChange DetectedRevision updated to v3.3.1, and the previous revision v3.2.0 was removed.SummaryDifference0.0%

- Check85 days agoChange DetectedThe funding-status notice on the page was removed, and the core study information remains unchanged; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to CANDOR Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CANDOR Clinical Trial page.